|
Market Closed -
London S.E.
11:35:15 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 3.800 GBX | +2.70% |
|
-1.30% | -38.71% |
| 10-16 | WINNERS & LOSERS: Iofina falls as output weaker than expected | AN |
| 10-08 | WINNERS & LOSERS: Kelso buys into Likewise; Litigation Capital plunges | AN |
Company Valuation: ImmuPharma plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 33.4 | 16.51 | 6.135 | 6.942 | 5.018 | 31.17 |
| Change | - | -50.56% | -62.85% | 13.16% | -27.71% | 521.13% |
| Enterprise Value (EV) 1 | 28.18 | 14.87 | 5.467 | 6.734 | 4.781 | 29.82 |
| Change | - | -47.25% | -63.23% | 23.17% | -28.99% | 523.63% |
| P/E | -3.89x | -2.03x | -1.46x | -2.06x | -2.01x | -16.8x |
| PBR | 3.46x | 4.26x | 2.43x | 6.57x | -9.25x | 45.4x |
| PEG | - | 0.4x | 0x | 0.1x | 0.1x | 0.4x |
| Capitalization / Revenue | 264x | 140x | - | - | - | - |
| EV / Revenue | 223x | 126x | - | - | - | - |
| EV / EBITDA | -5.2x | -2.95x | -1.88x | -2.23x | -1.83x | -11.9x |
| EV / EBIT | -5.04x | -2.88x | -1.8x | -2.2x | -1.79x | -11.8x |
| EV / FCF | -19x | -8.31x | -2.99x | -6.82x | -4.05x | -18.8x |
| FCF Yield | -5.26% | -12% | -33.5% | -14.7% | -24.7% | -5.33% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0343 | -0.0325 | -0.0126 | -0.0081 | -0.006 | -0.0037 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.1267 | 0.1184 | - | - | - | - |
| EBITDA 1 | -5.418 | -5.046 | -2.911 | -3.025 | -2.611 | -2.499 |
| EBIT 1 | -5.589 | -5.16 | -3.029 | -3.063 | -2.675 | -2.534 |
| Net income 1 | -6.86 | -8.174 | -3.807 | -2.922 | -2.483 | -1.808 |
| Net Debt 1 | -5.22 | -1.649 | -0.6677 | -0.2085 | -0.2369 | -1.352 |
| Reference price 2 | 0.1335 | 0.0660 | 0.0184 | 0.0167 | 0.0120 | 0.0620 |
| Nbr of stocks (in thousands) | 250,221 | 250,221 | 333,403 | 416,437 | 416,437 | 502,724 |
| Announcement Date | 4/29/21 | 5/24/22 | 6/6/23 | 6/5/24 | 5/20/25 | 6/2/26 |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 31.78M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| Average | 26.77x | 26.46x | 15.68x | 0.32% | 38.31B | |
| Weighted average by Cap. | 26.72x | 25.33x | 15.90x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMM Stock
- Valuation ImmuPharma plc
Select your edition
All financial news and data tailored to specific country editions
